Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Dow Inc
DOW
|
+$123M |
| 2 |
Newmont
NEM
|
+$77.1M |
| 3 |
Corteva
CTVA
|
+$72.5M |
| 4 |
Amcor
AMCR
|
+$60.2M |
| 5 |
Alibaba
BABA
|
+$47.4M |
Top Sells
| 1 |
DuPont de Nemours
DD
|
+$101M |
| 2 |
Apple
AAPL
|
+$94.5M |
| 3 |
GG
Goldcorp Inc
GG
|
+$78.3M |
| 4 |
Microsoft
MSFT
|
+$77.6M |
| 5 |
Pfizer
PFE
|
+$53.9M |
Sector Composition
| 1 | Technology | 19.94% |
| 2 | Healthcare | 14.68% |
| 3 | Consumer Discretionary | 11.95% |
| 4 | Communication Services | 10.13% |
| 5 | Industrials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Boyd Gaming
BYD
$6.79B
| $4.22M | ﹤0.01% |
156,600
+3,300
| +2% | +$88.9K |
|
1227
Avis
CAR
$5.47B
| $4.21M | ﹤0.01% |
119,800
| – | – |
|
1228
EXL Service
EXLS
$7.04B
| $4.21M | ﹤0.01% |
318,340
+6,000
| +2% | +$79.3K |
|
|
UCB
1229
United Community Banks, Inc.
UCB
$3.94B
| $4.21M | ﹤0.01% |
147,400
+10,300
| +8% | +$294K |
|
|
MIME
1230
DELISTED
Mimecast Limited
MIME
| $4.2M | ﹤0.01% |
89,900
+13,300
| +17% | +$621K |
|
1231
Granite Construction
GVA
$4.7B
| $4.19M | ﹤0.01% |
86,900
+1,500
| +2% | +$72.3K |
|
1232
Arrowhead Research
ARWR
$4.11B
| $4.18M | ﹤0.01% |
157,800
+13,400
| +9% | +$355K |
|
1233
Halozyme
HALO
$8.99B
| $4.17M | ﹤0.01% |
242,900
+5,800
| +2% | +$99.6K |
|
1234
LCI Industries
LCII
$2.43B
| $4.17M | ﹤0.01% |
46,300
+300
| +0.7% | +$27K |
|
1235
Healthcare Services Group
HCSG
$1.16B
| $4.16M | ﹤0.01% |
137,263
+2,800
| +2% | +$84.9K |
|
1236
Acadia Realty Trust
AKR
$2.64B
| $4.15M | ﹤0.01% |
151,700
+3,100
| +2% | +$84.8K |
|
1237
Innospec
IOSP
$2.05B
| $4.15M | ﹤0.01% |
45,503
+1,000
| +2% | +$91.2K |
|
|
CHK
1238
DELISTED
Chesapeake Energy Corporation
CHK
| $4.14M | ﹤0.01% |
10,626
-1,254
| -11% | -$489K |
|
|
WBT
1239
DELISTED
Welbilt, Inc.
WBT
| $4.14M | ﹤0.01% |
247,900
+5,100
| +2% | +$85.2K |
|
1240
Itron
ITRI
$5.47B
| $4.13M | ﹤0.01% |
66,000
+1,300
| +2% | +$81.3K |
|
1241
Pediatrix Medical
MD
$1.45B
| $4.13M | ﹤0.01% |
163,500
+600
| +0.4% | +$15.1K |
|
1242
Terex
TEX
$3.46B
| $4.11M | ﹤0.01% |
131,000
-3,300
| -2% | -$104K |
|
1243
RH
RH
$4.08B
| $4.11M | ﹤0.01% |
35,530
-1,000
| -3% | -$116K |
|
1244
uniQure
QURE
$904M
| $4.1M | ﹤0.01% |
52,500
+8,300
| +19% | +$649K |
|
1245
Empire State Realty Trust
ESRT
$1.34B
| $4.1M | ﹤0.01% |
276,800
+8,800
| +3% | +$130K |
|
1246
Coherent
COHR
$16B
| $4.1M | ﹤0.01% |
112,000
+1,900
| +2% | +$69.5K |
|
|
MDP
1247
DELISTED
Meredith Corporation
MDP
| $4.09M | ﹤0.01% |
74,300
+1,600
| +2% | +$88.1K |
|
1248
Matador Resources
MTDR
$5.93B
| $4.09M | ﹤0.01% |
205,602
+14,800
| +8% | +$294K |
|
1249
WD-40
WDFC
$2.86B
| $4.09M | ﹤0.01% |
25,700
+500
| +2% | +$79.5K |
|
1250
Taylor Morrison
TMHC
$6.88B
| $4.07M | ﹤0.01% |
194,300
-22,000
| -10% | -$461K |
|